Gas6/Axl Pathway Is Activated in Chronic Liver Disease and Its Targeting Reduces Fibrosis via Hepatic Stellate Cell Inactivation

Journal of Hepatology - Netherlands
doi 10.1016/j.jhep.2015.04.013